Intracranial Stents Market 2019 Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Size Analysis by Forecast to 2026

According to a report by Fortune Business Insights, titled “Intracranial Stents Market Size, Share and Global Trend by Product (Self-Expanding Intracranial Stents, Embolization Coil Support Intracranial Stents), By Disease Indication (Brain Aneurysm, Intracranial Stenosis), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and Geography Forecast till 2026,” the market derives growth from increasing regulatory approvals for related products.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/intracranial-stents-market-100396

Some of the major companies that are present in the Global Intracranial Stents Market are

  • Acandis GmbH
  • Abbott
  • Medtronic
  • Stryker
  • MicroPort Scientific India Pvt. Ltd.
  • DePuy Synthes Companies
  • Boston Scientific
  • Penumbra, Inc. and BALT EXTRUSION

The use of intracranial stents in maintaining blood flow in the brain has led to a huge demand. The intracranial stent is implanted inside the brain of the person suffering from brain aneurysms and intracranial stenosis. Intracranial stents also help in reducing chances of stroke in patients with symptomatic intracranial stenosis. According to the Brain Aneurysm Foundation, almost 6 million people in the United States are suffering from brain aneurysm. Furthermore, 30,000 people have undergone a brain rupture. Such high prevalence of brain aneurysm has led to the demand for intracranial stents. This, in turn will favor the growth of the global intracranial stents market in the forthcoming years.

Stryker gets FDA Nod for Neuroform AtlasTM Stent System

The growing prevalence of aneurysm on a global scale has created the demand for more treatment methods. On account of the high prevalence, regulatory authorities have eased off their reluctance in approving newer treatment methods and drugs. The global intracranial stents market is likely to benefit from usage approvals. In 2017, Stryker received approval from the Food and Drug Administration for its Neuroform AtlasTM Stent System for marketing under Humanitarian Device Exemption (HDE). The device was used for treatment of wide neck intracranial aneurysms. The AtlasTM is designed to improve wall apposition and increase deployment accuracy even in the most difficult cases. The device will aid the treatment options for aneurysms and this in turn, is likely to favor the growth of the global intracranial stents market in the forthcoming years.

Get Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intracranial-stents-market-100396

High Prevalence of Neurological Disorders is Creating High Demand

The high prevalence of neurological disorders has provoked several innovations in treatment options. According to the World Health Organization (WHO), between 1990 and 205, the number of deaths due to neurological disorders increased by 36.7%. The most commonly prevailing disorders were headache, Alzheimer’s disease and Dementias. Additionally, neurological disorders are major cause of disabilities worldwide. Such a high prevalence of neurological disorders will create a huge demand for devices for treatment of these disorders. Fortune Business Insights has predicted that the high prevalence of neurological disorders will have a positive impact on the global intracranial stents market in the coming years.

Fortune Business Insights has labelled increasing regulatory approvals as one of the leading factors that account for growth of the global intracranial stents market. Several companies have been encouraged by FDA’s recent trend of approval of related drugs and devices. Influenced by this factor companies have begun to shift their focus on the research and development of related products. Some of the leading companies that are operating in the global intracranial stents market are Acandis GmbH, Abbott, Medtronic, Stryker, MicroPort Scientific Corporation, DePuy Synthes, Boston Scientific Corporation, Penumbra, Inc. and BALT EXTRUSION.

View Related Report at

Plant-Based Supplements Market 2019: Company Profiles, Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2025

Molecular Diagnostics Market 2019 Industry Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study and Competitive Landscape

Molecular Diagnostics Market Worth US$ 8012.7 Mn by 2025 by Top International Players BD, Danaher Grifols, S.A., Hologic Inc., QIAGEN and More

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]